WO2001024766A1 - Antiperspirant compositions comprising microemulsions - Google Patents
Antiperspirant compositions comprising microemulsions Download PDFInfo
- Publication number
- WO2001024766A1 WO2001024766A1 PCT/EP2000/009144 EP0009144W WO0124766A1 WO 2001024766 A1 WO2001024766 A1 WO 2001024766A1 EP 0009144 W EP0009144 W EP 0009144W WO 0124766 A1 WO0124766 A1 WO 0124766A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- accordance
- antiperspirant
- salt
- microemulsions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Definitions
- This invention is related to microemulsions that contain cosmetically active ingredients.
- this invention is related to antiperspirant salt-containing microemulsions that are stable, clear liquids and are easy and inexpensive to produce.
- microemulsions of the present invention contain water.
- Microemulsions of the present invention are transparent or translucent, optically isotropic and thermodynamically stable mixtures of oil and water stabilized by surfactants and perhaps co-surfactants.
- the particle size of the dispersed phase of a microemulsion is about 100 to about 2000 angstroms, more preferably are about 100 to about 1000 angstroms. They can form spontaneously or with a little energy. Therefore they are simple to prepare and are not process dependent i.e. the order of addition of starting materials or speed / type of mixing is not critical to the preparation of the microemulsions. It would be desirable to formulate antiperspirant compositions using microemulsions because microemulsions are easy and inexpensive to process and can be inherently clear without requiring refractive index matching of the aqueous and non- aqueous phases .
- Microemulsions have attracted considerable technological and scientific interest.
- Water-in-oil (w/o) microemulsions containing water, an ionic surfactant, a cosurfactant and oil are the most investigated.
- the ionic surfactant- containing microemulsions usually exhibit stability over a large range of temperature. .
- inorganic salts When inorganic salts are added, the minimum surfactant level to form water-in-oil microemulsions will increase.
- the solubilization of aqueous phase into the oil phase decreases, while the liquid crystal area increases.
- Nonionic surfactant- containing water-in-oil microemulsions require a large amount of surfactant as well .
- nonionic surfactant-containing microemulsions commonly exhibit a small temperature range of stability
- Microemulsions exist in the following forms: as water- in-oil, oil-in-water or as a bicontinuous phase, which is also called the surfactant phase .
- the term "microemulsion means water-in-oil, oil-in-water or a bicontinuous phase, or mixtures thereof.
- Bicontinuous phase microemulsions are found to solubilize a high amount of water and oil with lower levels of surfactant.
- the region around a bicontinuous phase microemulsion may transition into a swollen lamellar phase, otherwise known as a liquid crystal phase, and in certain cases these phases (microemulsion and liquid crystal) may co-exist.
- phase exhibit birefringence, shear induced (streaming) birefringence, and are thixotropic, viscoelastic and transparent . Because some of these systems exhibit increased viscosity the technical literature may refer to them as microemulsion gels.
- antiperspirant compositions which contain high levels of antiperspirant salts, cosmetic oils and surfactants suitable for application to the axilla. It is also an object of the present invention to provide antiperspirant compositions that do not require refractive index matching of the aqueous and nonaqueous phases in order to be clear. It is also an object of the present invention to provide microemulsion antipersprirant compositions that require little energy to manufacture.
- U.S. Patent 5,162,378 discloses water in oil microemulsions comprising cetyl dimethicone copolyol, water, silicone, alcohol, and 5-40% by weight of one or more salts.
- U.S. Patent 5,705,562 discloses a method of spontaneously forming a highly stable clear microemulsion by combining water, a volatile cyclic methyl siloxane or a volatile linear methyl siloxane and a silicone polyether surfactant.
- U.S Patent 5,707,613 is in the same patent family as the just mentioned patent.
- WO 94/22420 is concerned with silicone-based skin care products, which are applied to the skin as aerosols and form a clear gel on the skin.
- WO 94/19000 discloses pharmaceutical compositions in the form of a microemulsion which comprise and oil, a mixture of high and low HLB surfactants in which the high HLB surfactant comprises an aliphatic, aryl or aliphatic- aryl sulfate or sulfosuccinate or salt thereof, an aqueous phase and a biologically active agent.
- WO 94/08610 discloses pharmaceutical compositions in the form of microemulsions which comprise an oil, a mixture of high and low HLB surfactants in which the high HLB surfactant comprises a medium-chain fatty acid salt, an aqueous phase and a biologically active agent.
- U.S. 5,575,990 discloses roll-on antiperspirant compositions which are clear and, when applied to the human skin, do not leave a visible white residue after drying.
- the clear antiperspirant roll -on compositions are stable under varying temperature conditions and provide a suitable cosmetically acceptable feel or sensation when applied to the human skin.
- U.S. 5,487,887 discloses roll-on antiperspirant compositions and more particularly concerns antiperspirant compositions which are clear and stable under varying temperature conditions and, when applied to the human skin, do not leave a visible white residue after drying.
- the compositions in the form of an oil-in-water microemulsion comprise an antiperspirant active 5-30, PEG-7-glyceryl cocoate 5-25, emollients 0.5-3, cyclomethicone 3-7, and water 53-60%.
- the invention relates to a composition in the form of a microemulsion comprising an antiperspirant salt, a cosmetic oil, and a combination of at least one cationic quaternary surfactant and at least one nonionic surfactant.
- the present invention is directed to antiperspirant salt-containing microemulsions that are stable and clear liquids, or clear antiperspirant gels.
- microemulsions containing cosmetic oils, antiperspirant salt, water, quaternary surfactants and nonionic surfactants have been discovered.
- the microemulsions are primarily composed of bicontinous phase but the compositions include water-in-oil, oil-in-water, and microemulsion gels (liquid crystals) .
- the microemulsions are novel antiperspirant compositions that can be used in different types of applicators such as roll-on, sponge, mousse, pad, wipe, brush, gel and aerosol or non-aerosol spray applicators.
- microemulsions discovered in this invention contain inorganic salts such as antiperspirant salts and cosmetic oils and the solubilization of high levels of both oil and aqueous solution of salts is achieved by incorporating combinations of a quaternary ammonium surfactant and a nonionic surfactant .
- the invention relates to a composition in the form of a microemulsion comprising an antiperspirant salt, cosmetic oils, and a combination of at least one cationic quaternary surfactant and at least one nonionic surfactant.
- the invention also relates to a method for controlling or preventing underarm perspiration and malodor, which comprises applying to the underarm area a composition according to the invention.
- microemulsions exhibit stability over a relatively large range of temperature.
- the viscosity ranges from a thick gel to a low viscosity sprayable liquid.
- the types of the microemulsions formed are dependent on the ratio of aqueous phase to the nonionic surfactant (s) and oil. When the percentage of the salt solution containing quaternary surfactant increases, the microemulsion changes from water-in-oil to oil-in-water type, and a bicontinuous microemulsion phase, or possibly a liquid crystal phase, will form in-between. •
- the microemulsions can contain a high level of inorganic salts .
- the microemulsions contain a quaternary surfactant and a nonionic surfactant.
- microemulsions contain cosmetically acceptable oils. • A method for controlling or preventing underarm perspiration and malodor, which can be applied to the underarm area .
- microemulsions can be accomplished by using various product dispensers .
- % means weight percent unless otherwise specified.
- cationic surfactant means quaternary ammonium surfactant.
- compositions of the invention can be made by known methods or by methods that are analogous to known methods.
- microemulsions mean stable clear microemulsions containing cosmetic oil; antiperspirant salts, water and surfactants.
- the microemulsions described herein are primarily composed of bicontinous phase but the compositions can include water-in-oil microemulsions.
- the compositions of the invention can also comprise a liquid crystal (that is, a microemulsion gel) . More specifically, the compositions of the invention are selected from the group consisting of a microemulsion, a liquid crystal (that is, microemulsion gel) , or a mixture of a microemulsion and a liquid crystal .
- the compositions of the invention comprise an antiperspirant salt, a cosmetic oil, and a combination of at least one cationic quaternary surfactant and at least one nonionic surfactant.
- compositions of the invention are novel antiperspirant compositions that can be used in different types of applicators such as roll -on, sponge, mousse, pad, brush, wipe, gel and aerosol or non-aerosol spray applicators.
- microemulsion compositions described contain antiperspirant salts and are clear and stable over a larger temperature range from room temperature to 45°C-50°C.
- the viscosity of some of the water-in-oil microemulsions are less than lOcst, therefore they are spray-able.
- the invention relates to a composition in the form of a microemulsion comprising an antiperspirant salt, cosmetic oils, and a combination of at least one cationic quaternary surfactant and at least one nonionic surfactant .
- Antiperspirant salts contained in these microemulsions include, but are not limited to, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate, aluminum chlorohydrex propylene glycol complex, aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrex propylene glycol complex, aluminum chlorohydrex polyethylene glycol complex, aluminum dichlorohydrex polyethylene glycol complex, aluminum sesquichlorohydrex polyethylene glycol complex, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium octach
- Antiperspirant actives for use herein are often selected from astringent active salts, including in particular aluminum, zirconium and mixed aluminum/zirconium salts, including both inorganic salts, salts with organic anions and complexes.
- astringent active salts include aluminum, zirconium and aluminum/zirconium halides and halohydrate salts, such as chlorohydrates .
- the level of hydration is variable for example wherein there are up to about 6 or higher water molecules .
- Zirconium actives can usually be represented by the empirical general formula: ZrO (OH) 2 n-n Z B z or a hydrate thereof in which z is a variable in the range of from 0.9 to 2.0 so that the value 2n-nz is zero or positive, n is the valence of B, and B is selected from the group consisting of chloride, other halide, sulphamate, sulfate and mixtures thereof. Possible hydration to a variable extent is represented by wH 2 0. It is preferable that B represents chloride and the variable z lies in the range from 1.5 to 1.87. In practice, such zirconium salts are usually not employed by themselves, but as a component of a combined aluminum and zirconium-based antiperspirant. The level of hydration is variable for example wherein there are up to about 6 or higher water molecules .
- zirconium salts may have coordinated and/or bound water in various quantities and/or may be present as polymeric species, mixtures or complexes.
- zirconium hydroxy salts often represent a range of salts having various amounts of the hydroxy group.
- Zirconium aluminum chlorohydrate may be particularly preferred.
- Antiperspirant complexes based on the above-mentioned astringent aluminum and/or zirconium salts can be employed.
- the complex often employs a compound with a carboxylate group, and advantageously this is an amino acid.
- suitable amino acids include dl-tryptophan, dl- ⁇ - phenylalanine, dl-valine, dl-methionine and ⁇ -alanine, and preferably glycine, which has the formula CH 2 (NH 2 ) COOH.
- Aluminum-Zirconium actives or ZAG actives generally contain aluminum, zirconium and chloride with an Al/Zr ratio in a range from 2 to 10, especially 2 to 6, an Al/Cl ratio from 2.1 to 0.9.
- ZAG actives also contain a variable amount of glycine.
- salts with an Al/Zr ratio greater than 2 also known as low- zirconium actives may be preferred. Actives of these preferred types are available from Westwood, from Summit and from Reheis.
- antiperspirant-salt actives include astringent titanium salts, for example those describe in GB 2299506A.
- the proportion of solid antiperspirant salt in a composition normally includes the weight of any water of hydration and any complexing agent that may also be present in the solid active. However, when the salt is in solution, its weight excludes any water present.
- the antiperspirant active will often provide from 1 to 60% by weight of the aqueous phase, particularly from 10% to 60% of the aqueous phase.
- the final content of the salts in the formulations can range from 0.1% to 40% but 5-35% is preferred.
- the microemulsions could solubilize aqueous solutions of monovalent, divalent and trivalent salts.
- the salts include sodium chloride, sodium sulfate, calcium chloride, calcium sulfate, magnesium chloride, aluminum sodium lactate, and mixtures thereof.
- ingredients which can be dissolved in the aqueous phase include buffers, glycols, sugars, cyclodextrins, preservatives, antimicrobials, fragrances, chelating agents, amino acids, antimicrobials, anticholinergics, water-soluble polymers etc.
- the antiperspirant salts or other aqueous phase ingredients can be dissolved into water first and then combined with the non-aqueous phase.
- Water content in the final formulations can range from 1% to 60%, 5% to 30% is preferred and 10% to 25% is the most preferred.
- the oil phase of the compositions of the invention can contain cosmetic oils such as esters, ethers, long chain alcohols or ethoxylated alcohols, hydrocarbons, fatty acids, monoglycerides , diglycerides or triglycerides, fragrances, volatile or non-volatile silicone fluids. Cholesterol and some other lipids can be incorporated with the oil phase to act as emollients.
- the oil phase concentration can range from 0% to 95%, but 20% to 60% is preferred.
- Silicone fluids that may be included in compositions of the invention include volatile and non-volatile silicone fluids such as cyclomethicones and dimethicones .
- Non-volatile silicones such as phenyl tris (trimethylsiloxy) silane can be included in compositions of the invention.
- Silicone elastomers such as DC 9040, or DC 9010 by Dow Corning or GE SFE 839 by General Electric, can be included in the compositions of the invention.
- Esters selected from the group consisting of cetyl octanoate, C12 -15 alcohol benzoate, isostearyl benzoate, diisopropyl adipate, isopropyl palmitate, isopropyl myristate and mixtures thereof may be included in the compositions of the invention.
- Hydrocarbon oils such as aliphatic hydrocarbons (Permethyl 102A TM, Permethyl 101TM) ; hydrogenated polybutenes ; hydrogenated polydecenes (SilkfloTM) ; dioctylcyclohexane; mineral oil, cyclohexane and mixtures thereof may be included in the compositions of the invention.
- Surfactants such as aliphatic hydrocarbons (Permethyl 102A TM, Permethyl 101TM) ; hydrogenated polybutenes ; hydrogenated polydecenes (SilkfloTM) ; dioctylcyclohexane; mineral oil, cyclohexane and mixtures thereof may be included in the compositions of the invention.
- Surfactants such as aliphatic hydrocarbons (Permethyl 102A TM, Permethyl 101TM) ; hydrogenated polybutenes ; hydrogenated polydecenes (SilkfloTM) ; dioctylcyclohexane
- Combinations of a cationic, quaternary ammonium surfactant (s) and a nonionic surfactant are employed in the compositions of the invention.
- the quaternary surfactant in this invention is essential, without which the formulation will be either extremely sensitive to temperature or a microemulsion will not form.
- the preferred cationic surfactants employed in compositions of the invention are alkylamidopropyl alkyldimonium quaternaries.
- the preferred cationic quaternary surfactants have the following structure :-
- a " is any physiologically acceptable counter ion which does not adversely affect the composition, and more specifically A " can be selected from the group consisting of chloride, bromide, ethosulfate, methyl sulfate, lactate, acetate, nitrate or sulfate.
- R is a ricinoleic derivative
- variations on this structure can also be incorporated into embodiments of this invention.
- the variations on surfactant structure should exhibit solubility in the aqueous antiperspirant salt solution. If the above mentioned solubility is maintained then variations in the quaternary ammonium salts can include but are not limited to, increasing or decreasing the alkyl chain length, changing the position or removal of the hydroxyl group, changing the position or removing completely the double bond or combinations thereof.
- the surfactant described just above is also known, under the following trade names, as Surfactol Q4 from CasChem Inc., Lipoquat R from Lipo Chemicals or Mackernium DC- 159 from Mclntyre Chemical.
- the quaternary surfactant is supplied in a concentrated form (>90% active) with a low free amine content . This form is readily miscible with the aqueous antiperspirant-salt solution.
- the quaternary surfactant (s) in the compositions of the invention range from 0.1% to 30%, where 2% to 15% is preferred.
- the nonionic surfactant or co-surfactants employed in the compositions of the invention can be polyethoxylated alcohol ethers or esters, polyglycerol mono or di-esters, glyceryl esters or branched guerbet ethoxylates or alcohols, or long chain carboxylic acids or combinations thereof. These compounds have a hydrophilic-lipophilic balance of between about 2 to about 15 and preferably less than about 12.
- Non-limiting examples are polyglycerol -3 diisostearate; glycerol oleate; poly glycerol-2 monoisostearate; polyglycerol -2 diisostearate, glyceryl isostearate.
- the most preferred ones are polyglyceryl-3 diisosterate, glyceryl isosterate and glycerol oleate or combinations thereof.
- the ratio of cationic surfactant to aqueous phase containing antiperspirant salt ranges from 30/70 to 4/96, the ratio from 10/90 to 5/95 is preferred.
- the ratio of aqueous phase including salts, water and cationic surfactant to nonionic surfactant is 90/10 to 70/30, and the ratio from 90/10 to 80/20 is preferred.
- the following samples are stable for one month at room temperature.
- the particle size or domain length of these compositions are between about 150 to about 600 angstroms. All samples are clear. Some samples exhibit streaming birefringence. Some samples exhibit birefringence.
- the viscosity of these samples range from a thin liquid to a gel. These microemulsions are primarily composed of bicontinous phase but the compositions include water-in-oil, and microemulsion gels (liquid crystals) .
- the aqueous phase is prepared by mixing the quaternary ammonium surfactant with the antiperspirant salt solution.
- compositions were prepared according to the following procedure :
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA02003348A MXPA02003348A (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions. |
CA002385917A CA2385917C (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions |
DE60017425T DE60017425T2 (en) | 1999-10-01 | 2000-09-18 | ANTITRANSPIRANT COMPOSITION CONTAINING MICROEMULSIONS |
EP00977406A EP1216015B1 (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions |
AU15138/01A AU1513801A (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions |
AT00977406T ATE286707T1 (en) | 1999-10-01 | 2000-09-18 | ANTIPERSPIRANT COMPOSITION CONTAINING MICROEMULSIONS |
US10/089,648 US6790435B1 (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15738299P | 1999-10-01 | 1999-10-01 | |
US60/157,382 | 1999-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001024766A1 true WO2001024766A1 (en) | 2001-04-12 |
Family
ID=22563482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/009144 WO2001024766A1 (en) | 1999-10-01 | 2000-09-18 | Antiperspirant compositions comprising microemulsions |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1216015B1 (en) |
CN (1) | CN1293861C (en) |
AR (1) | AR025913A1 (en) |
AT (1) | ATE286707T1 (en) |
AU (1) | AU1513801A (en) |
CA (1) | CA2385917C (en) |
CO (1) | CO5180588A1 (en) |
DE (1) | DE60017425T2 (en) |
MX (1) | MXPA02003348A (en) |
RU (1) | RU2260418C2 (en) |
WO (1) | WO2001024766A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083091A1 (en) * | 2001-04-11 | 2002-10-24 | Unilever Plc | Antiperspirant compositions comprising microemulsions |
DE10149362A1 (en) * | 2001-10-06 | 2003-04-30 | Beiersdorf Ag | Antiperspirant product based on microemulsions |
DE10149373A1 (en) * | 2001-10-06 | 2003-04-30 | Beiersdorf Ag | Antiperspirant product based on microemulsion gels |
WO2003053388A1 (en) * | 2001-12-21 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Deodorant foam |
WO2010097205A3 (en) * | 2009-02-27 | 2011-11-10 | Beiersdorf Ag | Use of loaded surfactants for reducing textile spotting due to antiperspirants |
WO2020109933A1 (en) * | 2018-11-30 | 2020-06-04 | 3M Innovative Properties Company | Topical antimicrobial microemulsions |
WO2020109934A1 (en) * | 2018-11-30 | 2020-06-04 | 3M Innovative Properties Company | Topical antimicrobial microemulsions with fluorescent materials |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009075678A1 (en) * | 2007-12-12 | 2009-06-18 | Colgate-Palmolive Company | Antiperspirant active compositions having sec chromatogram exhibiting high sec peak 4 intensity |
JP2009161474A (en) * | 2007-12-28 | 2009-07-23 | Nisshin Kagaku Kk | Antiperspiration spray composition |
US8815222B2 (en) * | 2009-12-23 | 2014-08-26 | Colgate—Palmolive Company | Anhydrous liquid antiperspirant composition |
EP2917318B1 (en) | 2012-11-09 | 2016-12-21 | Unilever N.V. | A composition and method for treating substrates |
CN103961267B (en) * | 2013-12-10 | 2018-04-03 | 北京德默高科医药技术有限公司 | A kind of composition of deodorization hidroschesis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278660A1 (en) * | 1987-02-03 | 1988-08-17 | Stiefel Laboratories (Ireland) Limited | Microemulsions |
US5487887A (en) * | 1993-10-28 | 1996-01-30 | Bristol-Myers Squibb Company | Clear antiperspirant roll-on compositions |
WO1997006777A1 (en) * | 1995-08-18 | 1997-02-27 | Colgate-Palmolive Company | Clear cosmetic gel composition |
-
2000
- 2000-09-18 CA CA002385917A patent/CA2385917C/en not_active Expired - Fee Related
- 2000-09-18 MX MXPA02003348A patent/MXPA02003348A/en active IP Right Grant
- 2000-09-18 EP EP00977406A patent/EP1216015B1/en not_active Expired - Lifetime
- 2000-09-18 RU RU2002111338/15A patent/RU2260418C2/en not_active IP Right Cessation
- 2000-09-18 AT AT00977406T patent/ATE286707T1/en not_active IP Right Cessation
- 2000-09-18 CN CNB008163049A patent/CN1293861C/en not_active Expired - Fee Related
- 2000-09-18 AU AU15138/01A patent/AU1513801A/en not_active Abandoned
- 2000-09-18 WO PCT/EP2000/009144 patent/WO2001024766A1/en active IP Right Grant
- 2000-09-18 DE DE60017425T patent/DE60017425T2/en not_active Expired - Lifetime
- 2000-09-27 CO CO00073359A patent/CO5180588A1/en not_active Application Discontinuation
- 2000-09-29 AR ARP000105147A patent/AR025913A1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278660A1 (en) * | 1987-02-03 | 1988-08-17 | Stiefel Laboratories (Ireland) Limited | Microemulsions |
US5487887A (en) * | 1993-10-28 | 1996-01-30 | Bristol-Myers Squibb Company | Clear antiperspirant roll-on compositions |
WO1997006777A1 (en) * | 1995-08-18 | 1997-02-27 | Colgate-Palmolive Company | Clear cosmetic gel composition |
Non-Patent Citations (1)
Title |
---|
SWAFFORD ET AL.: "Characterization of swollen micelles containing linoleic acid in a microemulsion system", J. SOC. COSMET. CHEM., vol. 42, no. 4, 1991, pages 235 - 247, XP000984183 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083091A1 (en) * | 2001-04-11 | 2002-10-24 | Unilever Plc | Antiperspirant compositions comprising microemulsions |
DE10149362A1 (en) * | 2001-10-06 | 2003-04-30 | Beiersdorf Ag | Antiperspirant product based on microemulsions |
DE10149373A1 (en) * | 2001-10-06 | 2003-04-30 | Beiersdorf Ag | Antiperspirant product based on microemulsion gels |
US7282196B2 (en) | 2001-10-06 | 2007-10-16 | Beiersdorf Ag | Antiperspirant product based on microemulsions |
WO2003053388A1 (en) * | 2001-12-21 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Deodorant foam |
US8691250B2 (en) | 2009-02-27 | 2014-04-08 | Beiersdorf Ag | Use of charged surfactants for reducing textile staining by antiperspirants |
WO2010097205A3 (en) * | 2009-02-27 | 2011-11-10 | Beiersdorf Ag | Use of loaded surfactants for reducing textile spotting due to antiperspirants |
EP3111916A1 (en) * | 2009-02-27 | 2017-01-04 | Beiersdorf AG | Use of charged surfactants for reducing textile staining by antiperspirants |
EP3120828A1 (en) * | 2009-02-27 | 2017-01-25 | Beiersdorf AG | Use of charged surfactants for reducing textile staining by antiperspirants |
US10105300B2 (en) | 2009-02-27 | 2018-10-23 | Beiersdorf Ag | Use of charged surfactants for reducing textile staining by antiperspirants |
US10111818B2 (en) | 2009-02-27 | 2018-10-30 | Beiersdorf Ag | Use of charged surfactants for reducing textile staining by antiperspirants |
US10172773B2 (en) | 2009-02-27 | 2019-01-08 | Beiersdorf Ag | Use of charged surfactants for reducing textile staining by antiperspirants |
WO2020109933A1 (en) * | 2018-11-30 | 2020-06-04 | 3M Innovative Properties Company | Topical antimicrobial microemulsions |
WO2020109934A1 (en) * | 2018-11-30 | 2020-06-04 | 3M Innovative Properties Company | Topical antimicrobial microemulsions with fluorescent materials |
Also Published As
Publication number | Publication date |
---|---|
DE60017425T2 (en) | 2005-06-02 |
ATE286707T1 (en) | 2005-01-15 |
CO5180588A1 (en) | 2002-07-30 |
RU2260418C2 (en) | 2005-09-20 |
EP1216015A1 (en) | 2002-06-26 |
CA2385917A1 (en) | 2001-04-12 |
AU1513801A (en) | 2001-05-10 |
EP1216015B1 (en) | 2005-01-12 |
RU2002111338A (en) | 2004-01-10 |
CN1293861C (en) | 2007-01-10 |
MXPA02003348A (en) | 2002-10-04 |
DE60017425D1 (en) | 2005-02-17 |
CA2385917C (en) | 2009-04-14 |
AR025913A1 (en) | 2002-12-18 |
CN1399536A (en) | 2003-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6790435B1 (en) | Antiperspirant compositions comprising microemulsions | |
US20030103921A1 (en) | Antiperspirant compositions comprising microemulsions | |
RU2340596C2 (en) | Antiperspirants based on salts aluminium/zirconium/glycine, stabilized with betaine | |
EP0852487B1 (en) | Antiperspirant deodorant compositions | |
US6403071B1 (en) | Anhydrous antiperspirant and deodorant compositions containing solid d-pantothenate salts | |
US20040198998A1 (en) | Glycine-free antiperspirant salts with betaine for enhanced cosmetic products | |
US20030165447A1 (en) | Topical leave-on compositions containing pantothenic acid and its derivatives to reduce the need for underarm shaving | |
JPH07304642A (en) | Anhidrotic deodorant composition | |
CA2385917C (en) | Antiperspirant compositions comprising microemulsions | |
EP2760414B1 (en) | Antiperspirant compositions and method for reducing perspiration | |
US8883130B2 (en) | Transparent antiperspirant gels | |
ZA200609416B (en) | Antiperspirant or deodorant compositions | |
EP1201226A2 (en) | Antiperspirant products made from wet-milled anhydrous antiperspirant salts | |
CA2082823A1 (en) | Liquid antiperspirant compositions | |
AU2004228006B2 (en) | Glycine-free antiperspirant salts with betaine for enhanced cosmetic products | |
US10342749B2 (en) | Antiperspirant compositions comprising alums | |
JP2004520416A (en) | Anhydrous antiperspirant and deodorant compositions containing solid, encapsulated D-pantothenate | |
AU2012314737B2 (en) | Antiperspirant compositions and method for reducing perspiration | |
WO2005063187A1 (en) | Cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000977406 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2385917 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2002/00370/MU Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/003348 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002111338 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008163049 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2000977406 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10089648 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000977406 Country of ref document: EP |